KLOW Peptide Dosage: Why No Human Dose Is Known
The short answer is that no human dose has been proved
The first KLOW sellers chose one vial for four study compounds. They didn’t have a human dose test.
KLOW peptide dosage is still unknown. No human or animal study tested an amount of the whole mixture.
The usual lab vial holds 80 mg: 50 mg of GHK-Cu, 10 mg of BPC-157, 10 mg of TB-500, and 10 mg of KPV. Those are package amounts.
Separate studies used separate amounts in rodents or loose cells. They don’t combine into one amount for your body.
The four parts also rise and fade in blood at different times. No one knows whether those different times help, hurt, or make no difference.
The figures below tell you what each paper used. They don’t give you a schedule.
Use those amounts only while reading the studies. They aren’t a plan for your day.
KLOW peptide dosage starts with the vial label, not proof
The usual KLOW lab vial holds 80 mg. Its label lists 50 mg of GHK-Cu, 10 mg of BPC-157, 10 mg of TB-500, and 10 mg of KPV.
That is the 50/10/10/10 ratio. The four parts can dissolve in the same water without becoming one new drug.
No test shows that they react to form one new substance. A different question is still open: copper may change one of the other parts while the vial sits.
Lab accounts add sterile water made to slow germ growth. They then describe a shot into the fat beneath the skin.
Other papers put GHK-Cu on skin or gave KPV by mouth. BPC-157 was given by mouth, into one area, or into a joint.
Those BPC-157 tests used one compound at a time. None proves a way to put the full blend into your body.
You can see how each test compound reached animals or cells. No fair test tells you how to give the vial.
KLOW dosage can’t be built by adding these study amounts
No human KLOW dose exists. The amounts below belong to separate studies and aren’t a plan.
KPV: A 2008 study used 10 nanomolar in human gut cells [3]. Nanomolar tells how much was mixed through the dish liquid; it isn’t a weight you can compare with milligrams on a vial.
The next test put 100 micromolar in mouse drinking water. Micromolar also tells how much was mixed through liquid, and the mice drank it rather than getting a set body amount.
The drinking-water test used living mice. The other test used loose cells, so neither amount turns into an amount for you.
GHK-Cu: A 2015 paper covered creams put on human skin [4]. Collagen tests used 1–10 nanomolar in dish liquid.
A 2018 review also used 1–10 nanomolar in skin cells [5]. Cream and dish amounts don’t give you a dose for the whole body.
BPC-157: A 2003 rat tendon test used 10 micrograms, 10 nanograms, or 10 picograms [2]. Each is a weight, with a nanogram equal to one billionth of a gram and a picogram equal to one trillionth.
The test put each amount into the rat’s belly once daily. All three groups grew stronger tendons and used the hurt leg better.
A 2025 first safety check used a vein in two adults [6]. They got 10 mg on day 1 and 20 mg on day 2 in 250 milliliters of salt water over one hour.
That check looked for harm, not the amount that works. Two people can’t answer that question for you.
TB-500 and thymosin beta-4: A 1999 rat wound test put thymosin beta-4 on skin and inside the belly [1]. About 10 picograms made loose skin cells move farther in a dish.
A 2004 hair-root study also used tiny lab amounts [11]. Both papers tested whole thymosin beta-4.
The short TB-500 product wasn’t tested at matching amounts. Keep every amount inside its own test; none becomes your vial dose.
KLOW peptide dosage and frequency need a doctor’s plan
The most structurally important dosage fact about KLOW is the pharmacokinetic mismatch inherent in the co-formulation. The four peptides have markedly different half-lives and clearance rates: the tripeptides KPV and GHK-Cu are small (MW 342 and 403 Da) and clear very quickly in plasma; BPC-157 is larger (MW 1419 Da) and has a short reported elimination half-life; TB-500 as the short heptapeptide fragment behaves differently from the full-length 43-amino-acid native Tβ4 whose pharmacokinetics are better characterized.
A pharmacokinetic mismatch (when co-formulated compounds have very different absorption and clearance rates) means a single co-formulated dose cannot hold all four components at matched exposures simultaneously. The peak plasma concentration of the tripeptides arrives and clears before the larger peptides reach their own peak. No study has characterized the pharmacokinetics of the four-peptide combination, and no dosing schedule has been validated that addresses this mismatch.
This is not a rhetorical point; it is a structural fact about the co-formulation that belongs in any honest discussion of KLOW dosage and frequency. The individual constituent doses from rodent models are presented in the section above for research context — they are not combinable into a validated 'KLOW dose.'
Every number in this section is a literature parameter, not a protocol — and in practice nobody assembling a KLOW regimen should be working from a webpage. The blend is dispensed as a single prescription: at Promise Peptides (mypromise.com), doctor-guided peptide therapy means a licensed clinician reviews the request, writes the regimen and adjusts it over time. That is what the 'prescribed' in this site's name refers to — the pharmacokinetics live here, the protocol lives with the prescriber.
KLOW dosage also depends on how the mixed vial holds up
KLOW is sold as powder with the water removed. Lab accounts add sterile water made to slow germ growth, then keep the vial cold.
GHK-Cu carries copper. In water, that copper may react with the other three parts.
No paper has tested whether that reaction happens. No paper says whether it would make the mixture weaker or less safe.
Each part may break down at a different speed after water is added. Copper gives GHK-Cu one more way to change.
The KLOW research page explains what each part was tested for. The references page lists the papers behind each amount.
You can know that the powder dissolves. You can’t know from current research how long every part in your vial stays sound.